NextFin

AstraZeneca (AZN) Closes Down 0.12% Amid Broader Market Decline on February 12, 2026

Summarized by NextFin AI
  • AstraZeneca PLC's stock opened at $202.52 on February 12, 2026, and closed at $204.52, reflecting a slight decrease of -0.12% from the previous closing price.
  • The stock reached an intraday high of $205.86 and a low of $202.10, indicating some volatility within a 1.84% trading range.
  • The broader market experienced a downturn, with the Dow Jones Industrial Average (DJIA) falling -1.34%, which may have influenced AstraZeneca's stock performance.
  • Despite the market conditions, no significant news related to AstraZeneca was reported, suggesting that external factors played a role in the stock's modest decline.

AstraZeneca PLC Market Performance Review (February 12, 2026)

Stock Price Movement

On February 12, 2026, AstraZeneca PLC (ADR), traded under the ticker symbol AZN, opened at a price of $202.52. Throughout the trading day, the stock experienced fluctuations, reaching a high of $205.86 and a low of $202.10. The closing price for the day was $204.52, which represents a decrease of $0.24 or a percentage change of -0.12% compared to the previous closing price of $204.76. The trading volume for AstraZeneca on this day was approximately 2.72 million shares, contributing to a total market value of around $5.57 billion.

Intraday Price Fluctuations

The stock exhibited a range of movements during the trading session. After opening at $202.52, AstraZeneca's price gradually increased, reaching its intraday high of $205.86 before retreating slightly to close at $204.52. The intraday low of $202.10 indicates that the stock experienced some volatility, but overall, it remained within a relatively narrow range, reflecting a trading range of approximately 1.84% throughout the day.

Market Context

The broader market on February 12, 2026, was characterized by a significant downturn. The Dow Jones Industrial Average (DJIA) closed at 49,451.98, down 669.42 points or approximately -1.34% from the previous day. This decline in the overall market could have contributed to AstraZeneca's modest decrease in stock price, as investor sentiment was likely affected by broader economic concerns and market conditions.

While specific news or events directly related to AstraZeneca on this day were not reported, it is essential to consider the context of the pharmaceutical sector, which can be influenced by factors such as regulatory approvals, drug performance, and competitive dynamics. However, no significant announcements or press releases were found that could have directly impacted AstraZeneca's stock price on this date.

Summary of Key Data Points

  • Opening Price: $202.52
  • Closing Price: $204.52
  • Highest Price: $205.86
  • Lowest Price: $202.10
  • Change from Previous Close: -$0.24
  • Percentage Change: -0.12%
  • Trading Volume: 2.72 million shares
  • Market Capitalization: Approximately $5.57 billion

Conclusion

AstraZeneca PLC's stock performance on February 12, 2026, reflected a slight decline amidst a broader market downturn. The stock's intraday movements indicate a degree of volatility but remained within a narrow range, suggesting that while there were fluctuations, the overall investor sentiment was cautious, likely influenced by external market conditions rather than specific company news. As always, investors should consider both company-specific factors and broader market trends when evaluating stock performance.

Explore more exclusive insights at nextfin.ai.

Insights

What are the main factors influencing AstraZeneca's stock price movement?

How does AstraZeneca's market capitalization compare to its competitors?

What recent trends have been observed in the pharmaceutical sector affecting AstraZeneca?

What recent policy changes might impact AstraZeneca's stock performance?

How did the broader market impact AstraZeneca's stock performance on February 12, 2026?

What are the potential long-term impacts of current market conditions on AstraZeneca?

What challenges does AstraZeneca face in the current market environment?

What controversies have emerged regarding AstraZeneca's drug performance?

How does AstraZeneca's trading volume compare to its historical averages?

What are the implications of AstraZeneca's stock price volatility for investors?

What factors contributed to the Dow Jones Industrial Average's decline on the same day?

How does AstraZeneca's stock performance correlate with regulatory approvals in the industry?

What lessons can be learned from AstraZeneca's stock performance during market downturns?

What role do investor sentiments play in AstraZeneca's stock price fluctuations?

How does AstraZeneca's stock performance reflect broader economic concerns?

What are the key metrics to watch for AstraZeneca in the upcoming quarters?

What historical events have significantly impacted AstraZeneca's stock price?

How does AstraZeneca's stock performance compare with those of its main competitors?

What predictions can be made about AstraZeneca's stock future based on current trends?

Search
NextFinNextFin
NextFin.Al
No Noise, only Signal.
Open App